HomeCompareTOSCF vs MRK

TOSCF vs MRK: Dividend Comparison 2026

TOSCF yields 3.44% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TOSCF wins by $3.98M in total portfolio value
10 years
TOSCF
TOSCF
● Live price
3.44%
Share price
$17.00
Annual div
$0.58
5Y div CAGR
69.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.04M
Annual income
$3,130,504.15
Full TOSCF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — TOSCF vs MRK

📍 TOSCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTOSCFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TOSCF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TOSCF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TOSCF
Annual income on $10K today (after 15% tax)
$292.45/yr
After 10yr DRIP, annual income (after tax)
$2,660,928.53/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, TOSCF beats the other by $2,652,600.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TOSCF + MRK for your $10,000?

TOSCF: 50%MRK: 50%
100% MRK50/50100% TOSCF
Portfolio after 10yr
$2.05M
Annual income
$1,570,151.15/yr
Blended yield
76.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TOSCF
No analyst data
Altman Z
3.1
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TOSCF buys
0
MRK buys
0
No recent congressional trades found for TOSCF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTOSCFMRK
Forward yield3.44%2.76%
Annual dividend / share$0.58$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR69.6%32.7%
Portfolio after 10y$4.04M$56.8K
Annual income after 10y$3,130,504.15$9,798.13
Total dividends collected$3.94M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TOSCF vs MRK ($10,000, DRIP)

YearTOSCF PortfolioTOSCF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,284$583.52$11,206$366.19+$78.00TOSCF
2$13,117$1,043.63$12,650$502.35+$467.00TOSCF
3$15,958$1,922.99$14,407$694.19+$1.6KTOSCF
4$20,783$3,708.24$16,585$967.82+$4.2KTOSCF
5$29,893$7,655.00$19,342$1,363.89+$10.6KTOSCF
6$49,438$17,451.92$22,913$1,947.19+$26.5KTOSCF
7$98,646$45,747.79$27,662$2,823.89+$71.0KTOSCF
8$250,240$144,688.34$34,159$4,173.35+$216.1KTOSCF
9$849,527$581,770.25$43,337$6,308.80+$806.2KTOSCF
10$4,039,498$3,130,504.15$56,776$9,798.13+$3.98MTOSCF

TOSCF vs MRK: Complete Analysis 2026

TOSCFStock

Tosoh Corporation manufactures and sells basic chemicals, petrochemicals, specialty products, and fine chemicals worldwide. It operates through four segments: Petrochemical, Chlor-Alkali, Specialty, and Engineering. The company provides advance materials, including battery, fabricated quartzware, silica glass, thin film depositions, zeolites for catalysts and molecular sieves, zirconia injection mold components and compounds, zirconia grinding and dispersion media, and zirconia fine beads and powders. It also offers chromatographic columns, and media and diagnostic systems; clinical diagnostic systems; Portland cement and blast-furnace slag cement; and caustic soda, vinyl chloride monomer, calcium hypochlorite, and sodium bicarbonate. In addition, the company provides ethylene, propylene, C4 fraction, tertiary butyl alcohol, cumene, and aromatic compounds; and ethyleneamines, bromine, hydrobromic acids, flame retardants, non-aqueous solvents, chelating agents, ethylene dichloride, and sodium styrenesulfonate. Further, it offers polymers, such as ethylene vinyl-acetate copolymers, adhesive polymers, low and high-density polyethylene products, synthetic rubbers, functional polymers, and polyvinyl chloride pastes; and polyurethanes (PU), including methylene diphenyl diisocyanate, toluene diisocyanate, hexamethylene diisocyanate, adhesives, coating resins, elastomers, polyisocyanates for PU paints, and polyols. The company manufactures and sells water treatment systems; and engages in the construction and repair businesses. It serves chemical and petrochemical, construction, automotive, consumer electronics, information technology, bioscience, and environmental markets. The company was incorporated in 1935 and is headquartered in Minato, Japan.

Full TOSCF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TOSCF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TOSCF vs SCHDTOSCF vs JEPITOSCF vs OTOSCF vs KOTOSCF vs MAINTOSCF vs JNJTOSCF vs ABBVTOSCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.